DK1224166T3 - Fremgangsmåde til fremstilling af N-(4,5-bis-methansulfonyl-2-methyl-benzoyl)-guanidin-hydrochlorid - Google Patents

Fremgangsmåde til fremstilling af N-(4,5-bis-methansulfonyl-2-methyl-benzoyl)-guanidin-hydrochlorid

Info

Publication number
DK1224166T3
DK1224166T3 DK00972725T DK00972725T DK1224166T3 DK 1224166 T3 DK1224166 T3 DK 1224166T3 DK 00972725 T DK00972725 T DK 00972725T DK 00972725 T DK00972725 T DK 00972725T DK 1224166 T3 DK1224166 T3 DK 1224166T3
Authority
DK
Denmark
Prior art keywords
preparation
methanesulfonyl
benzoyl
bis
methyl
Prior art date
Application number
DK00972725T
Other languages
English (en)
Inventor
Rolf Gericke
Manfred Baumgarth
Hans Markus Bender
Bernhard Ladstetter
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Application granted granted Critical
Publication of DK1224166T3 publication Critical patent/DK1224166T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00Preparation of sulfones; Preparation of sulfoxides
    • C07C315/04Preparation of sulfones; Preparation of sulfoxides by reactions not involving the formation of sulfone or sulfoxide groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00Preparation of sulfones; Preparation of sulfoxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/44Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK00972725T 1999-10-26 2000-10-11 Fremgangsmåde til fremstilling af N-(4,5-bis-methansulfonyl-2-methyl-benzoyl)-guanidin-hydrochlorid DK1224166T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19951418A DE19951418A1 (de) 1999-10-26 1999-10-26 Verfahren zur Herstellung von N-(4,5-Bismethansulfonyl-2-methyl-benzoyl) -guanidin, Hydrochlorid
PCT/EP2000/009977 WO2001030750A1 (de) 1999-10-26 2000-10-11 Verfahren zur herstellung von n-(4,5-bis-methansulfonyl-2-methyl-benzoyl)-guanidin, hydrochlorid

Publications (1)

Publication Number Publication Date
DK1224166T3 true DK1224166T3 (da) 2004-01-05

Family

ID=7926842

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00972725T DK1224166T3 (da) 1999-10-26 2000-10-11 Fremgangsmåde til fremstilling af N-(4,5-bis-methansulfonyl-2-methyl-benzoyl)-guanidin-hydrochlorid

Country Status (25)

Country Link
US (1) US6673968B1 (da)
EP (1) EP1224166B1 (da)
JP (1) JP4969750B2 (da)
KR (1) KR100699571B1 (da)
CN (1) CN1202078C (da)
AT (1) ATE250026T1 (da)
AU (1) AU782471B2 (da)
BR (1) BR0015022A (da)
CA (1) CA2388915C (da)
CZ (1) CZ299201B6 (da)
DE (2) DE19951418A1 (da)
DK (1) DK1224166T3 (da)
ES (1) ES2204712T3 (da)
HU (1) HU228634B1 (da)
MX (1) MXPA02004144A (da)
MY (1) MY122651A (da)
NO (1) NO328250B1 (da)
PL (1) PL199010B1 (da)
PT (1) PT1224166E (da)
RU (1) RU2276134C2 (da)
SI (1) SI1224166T1 (da)
SK (1) SK286603B6 (da)
UA (1) UA73329C2 (da)
WO (1) WO2001030750A1 (da)
ZA (1) ZA200204119B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10023405A1 (de) * 2000-05-12 2001-11-15 Merck Patent Gmbh Verfahren zur Herstellung von Sulfonyl-benzoylguanidinum-Salzen
BRPI0410022A (pt) * 2003-05-06 2006-04-25 Merck Patent Gmbh processo para a cristalização de sais de guanidìnio
DK2271327T3 (da) 2008-05-09 2015-07-13 Merck Patent Gmbh Farmaceutisk sammensætning omfattende rimeporid til behandling af sygdomme forbundet med beta-celle-dysfunktion
CN105358530A (zh) * 2013-06-10 2016-02-24 美国安进公司 制备mdm2抑制剂的方法及其结晶形式
EP3159347A4 (en) * 2014-06-23 2018-01-24 Nissan Chemical Industries, Ltd. Method for producing sulfonyl-bond-containing silane compound
CN117304079A (zh) * 2016-02-08 2023-12-29 默克专利股份有限公司 N-(4,5-双甲磺酰基-2-甲基苯甲酰基)胍盐酸盐和n-(4,5-双甲磺酰基-2-甲基苯甲酰基)胍盐的结晶变体
EP3960165A1 (en) * 2020-08-25 2022-03-02 Fondation EspeRare Nhe-1 inhibitors for the treatment of coronavirus infections

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59216865A (ja) * 1983-05-26 1984-12-06 Mitsui Toatsu Chem Inc システイン塩酸塩水和物の乾燥方法
DE3929582A1 (de) * 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
EP0589336B1 (de) * 1992-09-22 1997-01-08 Hoechst Aktiengesellschaft Benzoylguanidine, Verfahren zu ihrer Herstellung, sowie ihre Verwendung als Antiarrhythmika
EP0604852A1 (de) * 1992-12-28 1994-07-06 Hoechst Aktiengesellschaft 2,4-Substituierte 5-(N-substituierte-Sulfamoyl)-Benzoylguanidine, als Antiarrythmika, Inhibitoren der Proliferationen von Zellen, und Inhibitoren des Natrium-Protonen-Antiporters
JPH07206857A (ja) * 1993-12-28 1995-08-08 Synthelabo Sa アルフゾシン塩酸塩の二水和物
JP3755908B2 (ja) * 1994-08-17 2006-03-15 塩野義製薬株式会社 セファロスポリン化合物の晶析法
EP0723956B1 (de) * 1995-01-30 1999-10-13 Hoechst Aktiengesellschaft Basisch-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19502895A1 (de) * 1995-01-31 1996-08-01 Merck Patent Gmbh 4-Mercapto-benzoylguanidin-Derivate
DE19526381A1 (de) * 1995-07-19 1997-01-23 Hoechst Ag 4-Fluoralkyl-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19529612A1 (de) * 1995-08-11 1997-02-13 Merck Patent Gmbh Sulfonyl- oder Sulfinyl-benzoylguanidin-Derivate

Also Published As

Publication number Publication date
MY122651A (en) 2006-04-29
NO20021950D0 (no) 2002-04-25
CN1202078C (zh) 2005-05-18
PL355149A1 (en) 2004-04-05
ATE250026T1 (de) 2003-10-15
ES2204712T3 (es) 2004-05-01
DE19951418A1 (de) 2001-05-03
KR20020044572A (ko) 2002-06-15
AU782471B2 (en) 2005-08-04
ZA200204119B (en) 2003-10-29
MXPA02004144A (es) 2006-01-12
SI1224166T1 (en) 2004-04-30
CZ299201B6 (cs) 2008-05-14
HUP0203132A2 (hu) 2003-01-28
CA2388915A1 (en) 2001-05-03
CN1382120A (zh) 2002-11-27
CA2388915C (en) 2009-12-15
BR0015022A (pt) 2002-06-18
AU1136101A (en) 2001-05-08
NO328250B1 (no) 2010-01-18
HUP0203132A3 (en) 2004-12-28
NO20021950L (no) 2002-04-25
EP1224166A1 (de) 2002-07-24
SK5462002A3 (en) 2002-10-08
DE50003759D1 (de) 2003-10-23
US6673968B1 (en) 2004-01-06
RU2276134C2 (ru) 2006-05-10
PL199010B1 (pl) 2008-08-29
WO2001030750A1 (de) 2001-05-03
SK286603B6 (sk) 2009-02-05
HK1051358A1 (en) 2003-08-01
UA73329C2 (uk) 2005-07-15
PT1224166E (pt) 2004-02-27
CZ20021354A3 (cs) 2002-09-11
JP4969750B2 (ja) 2012-07-04
HU228634B1 (en) 2013-04-29
JP2003512451A (ja) 2003-04-02
EP1224166B1 (de) 2003-09-17
KR100699571B1 (ko) 2007-03-23

Similar Documents

Publication Publication Date Title
DE69729583D1 (de) N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3-on derivative als faktor xa inhibitoren
EP1442016A4 (en) 1H-INDOLDERIVATE AS HIGH-DETECTIVE CYCLOOXYGENASE-2 INHIBITORS
DK1542977T3 (da) 2,5-dioxoimidazolidin-4-ylacetamider og analoger som inhibitorer af metalloproteinase MMP12
DK0931060T3 (da) Substituerede N-(aminoiminomethyl- eller aminomethyl)phenylpropyl-amider
DK1200418T3 (da) Nematodicide trifluorbutener
DK1456212T3 (da) 6-aminomorphinanderivater, fremgangsmåder til fremstilling heraf og disses anvendelse
ATE457977T1 (de) Biguanidderivate
DK0810991T3 (da) 1-Aryl-2-acylamino-ethan-forbindelser og deres anvendelse som neurokinin- især neurokinin-1-antagonister
DK1224166T3 (da) Fremgangsmåde til fremstilling af N-(4,5-bis-methansulfonyl-2-methyl-benzoyl)-guanidin-hydrochlorid
DK0870763T3 (da) Kondenserede piperidinderivater som inhibitorer for syntese af nitrogenmonoxid
DK1161239T3 (da) 3- cyclopropylmethoxy-4-difluormethoxy-N-(3,5-dichlorpyrid-4-yl)benzamid til behandling af dissemineret sklerose
DE60216948D1 (en) 4'-methansulfonylbiphenylderivate als hochselektive cyclooxygenase-2-inhibitoren
DK1373232T3 (da) Fremgangsmåde til fremstilling af N-substituerede 2,6-dialkylmorpholiner
DE60116514D1 (de) Amlodipin-hemimaleat
DK1177191T3 (da) Substituerede benzimidazoler, fremstilling og anvendelse deraf som midler til bekæmpelse af parasitiske protozoer
DE50311388D1 (de) Nicht-peptidische brs-3-agonisten
ATE223405T1 (de) Modifizierte form des hydrochlorids der r(-)-n-(4,4-di(-3-methylthien-2-yl)but-3-enyl)- nipecotinsäure
ATE242763T1 (de) Methoximinophenylessigsäureamide
ATE213236T1 (de) Substituierte benzyloxyimino-verbindungen
DK0971907T3 (da) Fremgangsmåde til fremstilling af 1,3-disubstituerede 2-nitroguanidiner
NO20021821L (no) Natrium-hydrogen utvekslingstype 1 inhibitor krystaller
AR026231A1 (es) Proceso para preparar clorhidrato de n-(4,5-bis-metansulfonil-2-metilbenzoil)-guanidina
BR0108622A (pt) Processo para a n-formilação seletiva de n-hidroxil aminas
ATE349427T1 (de) Tryptaseinhibitoren
NO20022844D0 (no) N-(1-fenyletyl)-5-fenyl-imidazol-2-aminforbindelser, deres sammensetninger og anvendelser